Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diabetes and Endo
    • New glucose monitoring...

    New glucose monitoring system leads to better blood sugar control in diabetes: Lancet

    Written by Medha Baranwal Baranwal Published On 2019-03-22T20:20:52+05:30  |  Updated On 22 March 2019 8:20 PM IST
    New glucose monitoring system leads to better blood sugar control in diabetes: Lancet

    The new glucose monitoring system that includes automated insulin titration guidance under medical supervision leads to better blood sugar control in diabetes.


    In patients with type 2 diabetes, insulin therapy is most effective when the dosage titrations are done regularly and frequently. But this is seldom practical for most clinicians, resulting in an insulin titration gap. A recent study published in the journal Lancet has found that a combination of automated insulin titration guidance with support from health-care professionals facilitates safe and effective insulin titration. The combination also offered superior glycaemic control compared with support from health-care professionals alone.


    Richard M Bergenstal, International Diabetes Center, Minneapolis, USA, and colleagues evaluated the effectiveness and safety of a novel system (d-Nav Insulin Guidance System) that measures, records, and analyzes scheduled fingerstick blood glucose levels and uses an algorithm to recommend insulin dose adjustments directly to patients. About 180, type 2 diabetes patients were randomized to receive usual support from healthcare professionals with or without using the new system.


    The primary objective was to compare average change in HbA 1c from baseline to 6 months. Safety was assessed by the frequency of hypoglycaemic events. The primary objective and safety were assessed in the intention-to-treat population.


    Key findings of the study include:

    • Eligible patients had glycosylated hemoglobin (HbA1c) levels between 7.5% and 11.0%, despite the use of a stable insulin regimen (long-acting, biphasic, or basal-bolus, with or without other medications) for at least 3 months.

    • At baseline, the mean HbA1c level was about 8.6% in both groups.

    • After 6 months, the mean HbA1c level declined by 1.0% in the intervention group and by 0.3% in the control group — a significant difference.

    • No difference was noted in the frequency of hypoglycemic events.

    • On average, the system algorithm adjusted insulin doses 1.1 times weekly.

    • At study's end, total daily insulin doses for system users were more than 60% higher than those for control patients.


    "The system now needs to be evaluated across large health-care systems to confirm these findings and study cost-effectiveness," concluded the authors.


    For detailed study log on to https://doi.org/10.1016/S0140-6736(19)30368-X
    d-Nav Insulin Guidance Systemdiabetesdiabetes treatmentglucose monitoring systemGlycaemic Controlglycosylated hemoglobinHbA1cinsulininsulin doseinsulin managementinsulin therapyinsulin titrationLancetnewType-2 diabetes
    Source : With inputs from Lancet

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok